The US Patent Holdings of Homegrown Indian Biotech and Pharma Companies

Current Science, 96, 252-259, 2009

Posted: 31 Jan 2016 Last revised: 27 Feb 2016

See all articles by Sriramkumar Sundaramoorthy

Sriramkumar Sundaramoorthy

Institute of Bioinformatics and Applied Biotechnology

Chandra Bindu Yerram

Institute of Bioinformatics and Applied Biotechnology

Ritu Mehdiratta

Independent

Gayatri Saberwal

Institute of Bioinformatics and Applied Biotechnology

Date Written: January 25, 2009

Abstract

We have examined all the US patents (444) issued to homegrown Indian pharma and pharma biotech firms. Most (425, 95%) patents are pharma patents not biotech (19). Also, only 11 patents have been cited ten times or more. This data provides one snapshot of the biotech industry in India today. It will serve as a baseline for the scenario in future.

(Article freely downloadable from the journal website.)

Keywords: Biotech and pharma industries, industrial R&D, patents

JEL Classification: H51, I10, L00, L65, O31, O32, O33, O34, O51, O53

Suggested Citation

Sundaramoorthy, Sriramkumar and Yerram, Chandra Bindu and Mehdiratta, Ritu and Saberwal, Gayatri, The US Patent Holdings of Homegrown Indian Biotech and Pharma Companies (January 25, 2009). Current Science, 96, 252-259, 2009, Available at SSRN: https://ssrn.com/abstract=2724522

Sriramkumar Sundaramoorthy

Institute of Bioinformatics and Applied Biotechnology ( email )

Biotech Park
Electronics City Phase 1
Bengaluru, Karnataka 560100
India

Chandra Bindu Yerram

Institute of Bioinformatics and Applied Biotechnology ( email )

Biotech Park
Electronics City Phase 1
Bengaluru, Karnataka 560100
India

Ritu Mehdiratta

Independent ( email )

Gayatri Saberwal (Contact Author)

Institute of Bioinformatics and Applied Biotechnology ( email )

Biotech Park
Electronics City Phase 1
Bengaluru, Karnataka 560100
India

Do you have a job opening that you would like to promote on SSRN?

Paper statistics

Abstract Views
232
PlumX Metrics